Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
440.0000 0.10 (0.02%)
NSE Jul 03, 2026 15:31 PM
Volume: 1.0M
 

440.00
0.02%
ICICI Securities Limited
With elite client additions like Amgen, Zoetis, Herbalife, GSK, etc, and multiple year extension of BMS, Baxter contracts, the company remains well poised to capture opportunities in the global CRO space...
Number of FII/FPI investors decreased from 265 to 226 in Mar 2026 qtr
More from Syngene International Ltd.
Recommended